Premature Ejaculation Treatment Market 2021 : An Amazing Industry Growth Factor For Next.!
Premature Ejaculation Treatment Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the world Premature Ejaculation Treatment Market.
Ejaculation is the process of releasing sperm from the body. PE, also known as rapid ejaculation, premature climax, or early ejaculation, is a condition in which a man’s or his partner’s ejaculation occurs earlier than desired during a sexual encounter. The inability to delay ejaculation for more than one minute after penetration is the most common symptom of PE. PE can be divided into two categories: lifelong (primary) and acquired (secondary) PE. PE (primary) is a condition that affects a man for the rest of his life, almost from the first sexual contact. PE is acquired (secondary) when a man who has had a normal sex life develops the ailment. Early sexual experiences, sexual abuse, poor body image, depression, anxiety, aberrant hormone levels, hereditary features, inflammation and infection of the prostate or urethra, and concern about premature ejaculation are some of the psychological and biological variables that can cause PE. Frequent launches and approvals of novel premature ejaculation treatment products is expected to drive growth of the market
The industry’s major players are concentrating on releasing new products, which is predicted to help the market grow. Absorption Pharmaceuticals, LLC, for example, introduced Promescent, an over-the-counter lidocaine-based spray for premature ejaculation, in 2012.Moreover, in 2013, Absorption Pharmaceuticals, LLC received patent for its Promescent, for premature ejaculation (PE) from the U.S. Patent and Trademark Office. In the near future, the worldwide premature ejaculation treatment market is projected to be fueled by the introduction of novel medications that are indicated for the treatment of premature ejaculation.
The global premature ejaculation treatment market size was valued at US$ 1.5 Bn in 2017, and is expected to witness a CAGR of 8.7% over the forecast period (2018 – 2026).
Increasing strategic collaborations for development of new diagnostic tools is expected to propel the market growth
Strategic cooperation between key market participants are underway for the development of medications to treat premature ejaculation. Ampio Pharmaceuticals, Inc., for example, signed a strategic arrangement with Ethypharm S.A. in 2012 to manufacture Zertane, Ampio’s medication for the treatment of premature ejaculationIn 2013, Absorption Pharmaceuticals LLC and Kaiser Permanente formed a strategic partnership to begin a clinical research to examine the efficacy of Promescent lidocaine spray for males with premature ejaculation (PE). The global premature ejaculation treatment market is likely to be fuelled by strategic cooperation between key players in the research, production, and assessment of novel medications. Furthermore, significant players are active in generating funding for drug development and are concentrating on growing their sales network in order to boost sales. For example, Absorption Pharmaceuticals LLC, the maker of Promescent spray, which is used to treat premature ejaculation, expanded its worldwide sales staff in 2013. Vyrix Pharmaceuticals, Inc., a subsidiary of AstraZeneca, was founded in 2014.Increasing prevalence of premature ejaculation is expected to increase demand for premature ejaculation drugs. For instance, according to the data published by European Association of Urology in 2017, the prevalence rate of premature ejaculation in the U.S. was estimated to be 30% (18-29 years), 32% (30-39 years), 28% (40-49 years), and 55% (50-59 years). According to the same source, the prevalence rate of four sub-types of erectile dysfunction was were 2.3% (lifelong PE), 3.9% (acquired PE), 8.5% (natural variable PE), and 5.1% (premature-like ejaculatory dysfunction). Such high prevalence of premature ejaculation is expected to lead to high demand for its treatment drugs and drive premature ejaculation treatment market growth.
The introduction of alternative treatment approaches for premature ejaculation is projected to be a major limiting factor for market growth. InnovaDerma PLC, for example, launched a device called Prolong in May 2018. The FDA-approved gadget Prolong is used to treat premature ejaculation. The global premature ejaculation therapy market is projected to be restrained by the introduction of such devices.
Major Key Players Include In Premature Ejaculation Treatment Market: Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.
Buy instant copy of this research report with Flat US $ 2000 Off@ – https://www.coherentmarketinsights.com/promo/buynow/1956
Main points in Premature Ejaculation Treatment Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Premature Ejaculation Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Premature Ejaculation Treatment Industry Impact
Chapter 2 Global Premature Ejaculation Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Premature Ejaculation Treatment (Volume and Value) by Type
2.3 Global Premature Ejaculation Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Premature Ejaculation Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Premature Ejaculation Treatment Market Analysis
Chapter 6 East Asia Premature Ejaculation Treatment Market Analysis
Chapter 7 Europe Premature Ejaculation Treatment Market Analysis
Chapter 8 South Asia Premature Ejaculation Treatment Market Analysis
Chapter 9 Southeast Asia Premature Ejaculation Treatment Market Analysis
Chapter 10 Middle East Premature Ejaculation Treatment Market Analysis
Chapter 11 Africa Premature Ejaculation Treatment Market Analysis
Chapter 12 Oceania Premature Ejaculation Treatment Market Analysis
Chapter 13 South America Premature Ejaculation Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Premature Ejaculation Treatment Business
Chapter 15 Global Premature Ejaculation Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
- CDN Newswire